#BIO2024 is approaching and we’re excited to see our CFO, Jami Rubin, sit down with Endpoints News' Drew Armstrong on Monday to discuss Jami’s career, deep expertise in biopharma and her journey to Boundless Bio. Learn more and join us: events.endpts.com/bio24/agenda?r…

We’ll be at the Goldman Sachs 45th Annual Global #Healthcare Conference, where our President & CEO, Zachary Hornby, & CFO, Jami Rubin, will take the stage for a fireside chat. Learn more about the event: investors.boundlessbio.com/news-releases/… Watch live: investors.boundlessbio.com/news-events/ev…

We're at #BIO2024 connecting with industry and partners. Chief Financial Officer, Jami Rubin, had a fireside chat with Endpoints News’ Executive Editor Drew Armstrong Monday morning to kick off the week.

Bump, set, spike. The first 2024 Boundless Bio sport tournament was a hit last week as teams of BoundTowners took to the courts to play it out in volleyball! Teammates had a blast competing for the top spot & tackling a new kind of teamwork. 🏐 Group 📸: Julius Apuy

We’re pleased to be at the Longwood Healthcare Leaders’ Spring 2024 MIT meeting next week where our Chief Business Officer, Neil Abdollahian, will moderate the “Navigating Partnerships Across Borders” panel. Register and join us: longwoodhealthcareleaders.com/spring2024

We’re extending a big Boundless welcome to our 2024 summer interns, Anjali Bose, Jackson Bishop, Wanyi Zhu, Katia Garcia, Abeni Thomas and Rand Ato. Last week they joined us for a welcome outing to Torrey Pines State Beach to kick off the summer together.

We joined FrontRunnersWalkrsSD #Pride 5K to volunteer last week & had a blast running the bag check & supporting Andy Kleinke, our CMC group’s Director of Drug Substance Development, who is the race's director! We’re always proud of our team’s contributions in and out of the office.

Happy #InternAppreciationDay to our team of wonderful interns! Anjali Bose, Jackson Bishop, Wanyi Zhu, Katia Garcia, Abeni Thomas & Rand Ato have spent the summer with us learning what it takes to bring new therapies to patients with oncogene amplified #cancer.

Patients whose cancers have oncogene amplification are in high unmet medical need as targeted therapies have been largely ineffective. We set out to improve & extend these patients' lives by developing ecDTx, an entirely new approach to #cancertreatment. boundlessbio.com

SVP Precision Medicine, Peter Krein will chair Day 3 of the 14th Annual CB & CDx Summit! Peter and David Lu will present on the development of our ecDNA technology and potential to support patients with oncogene amplified cancers. Learn more: ter.li/z9ikpv

Our 2024 Summer of Service was an impactful success. With the help of Life Science Cares San Diego, BoundTowners made a difference in our community with organizations like Feeding San Diego Wesley House Student Residence, Inc. Serving Seniors @MamasKitchenSD Ocean Discovery & The Links, Incorporated. Thank you to all!

We'll be attending the 2024 Cantor Global Healthcare Conference. This year, our CEO, Zachary Hornby, and CFO, Jami Rubin, will participate in a fireside chat to discuss the company’s progress. Learn more & join us for #CantorHC: investors.boundlessbio.com/news-releases/…

Our Associate Director of Biology, Sudhir Chowdhry will present “Intercepting Resistance Gene Amplifications in MAPK Pathway-Activated Cancers" at the RAS-Targeted Drug Development Summit. Learn more & join us: ras-drugdevelopment.com/whats-on/full-…

Our President & CEO, Zachary Hornby, will attend the Biocom California CEO Summit on 11/7 and take part in the “2024 IPOs: Lessons Learned and the Next Chapter” panel. Join Zach & other industry leaders for key insights & experiences that shaped their IPO process: biocom.org/conferences/ce…

You can catch Boundless Bio next week at the inaugural Guggenheim Healthcare Conference in Boston, MA! Our President and Chief Executive Officer, Zachary Hornby, will be in attendance to take part in a fireside chat. Join us and learn more: investors.boundlessbio.com/news-releases/…

Today #CancerGrandChallenges team eDyNAmiC and their international collaborators published 3️⃣ papers in nature 📣 They show the prevalence of ecDNA in cancer, identify fundamental mechanisms and an actionable target now being tested in the clinic. More: bit.ly/4dUMU00

Three #ecDNA publications in Nature today - congrats Mischel Lab and Howard Chang! One key paper highlights the importance of CHK1, a critical therapeutic vulnerability in ecDNA cancer, and the biological target of our lead program, BBI-355. More here: nature.com/articles/s4158…

Boundless Bio's Chief Executive Officer, Zachary Hornby will be at Piper Sandler's 36th Annual Healthcare Conference in New York, NY the first week of December for a fireside chat and Q&A. Don't miss the discussion and read more: investors.boundlessbio.com/news-releases/…

You can find us this week at #BiocomGPIC! Boundless CEO Zachary Hornby takes the stage Thursday morning at 11:15 AM to provide insights on the biotech IPO journey. Don’t miss this panel to hear first-hand about the path to going public.

See you @ #AACR25! Boundless co-founder Paul Mischel will help kick off the meeting during the opening plenary, sharing insights on #ecDNA in cancer & Rona Yaeger, a GI oncologist Memorial Sloan Kettering Cancer Center, will share research on BBI-825, an oral RNR inhibitor. abstractsonline.com/pp8/#!/20273/p…